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INTRODUCTION 
Bipolar affective disorder (BPAD) is defined as recurrent 
manic and depressive mood episodes. It is one of the most 
common mental disorder
1
. It is a complex medical illness of 
the brain. This illness expressed as an irregular pattern of 
changes in mood, energy and thinking. It is also known as 
manic depression disorder. It is a common psychiatric 
disorder which includes periods of extremely elevated mood
2
. 
The concept of bipolar disorder grew out of Emil Kraepelin’s 
classification of manic depressive insanity, which was 
postulated around the end of the 19
th
 century, however manic 
state can be found in the writing’s of Hippocrates and as far 
back as Egyptians. In 1957 Leonard coined the term ‘bipolar’ 
for those patients with depression who also experienced 
mania. In 1980 the name Bipolar disorder was adopted to 
replace the older term manic depression, which was tightly 
associated with psychosis
.3
. 
National collaborating centre for mental health reported that 
first-degree relatives of an individual with bipolar disorder 
face a life time risk of developing illness that is five to ten 
times greater than the general population. Stressful life events 
or alcohol abuse or nicotine abuse or drug abuse can make 
bipolar disorder more difficult to treat. This disorder is 
partially caused by imbalance of brain chemicals called 
neurotransmitters such as Nor-adrenaline (Nor-epinephrine), 
serotonin and dopamine
4
. 
Symptoms of mania include physical restlessness, increased 
talkativeness, racing thoughts, inflated self-esteem extending 
to delusions of grandeur, decreased sleep. These symptoms 
may lead to changes in both social and occupational function 
because of excessive behavior patterns
5
. Comorbidity is 
known to occur among various psychiatric disorders, however 
coexistence of obsessive compulsive disorder with mania is 
rare to see
6
. 
Bipolar patients have an unusually high incidence of 
Substance Use Disorders (SUD). Cigarette smoking (nicotine 
addiction) is also considered a substance use disorder. This 
nicotine abuse can reduce plasma levels of many medications 
used to manage bipolar disorder, making the disorder even 
more difficult for smokers to control
7
.
 
Obsessions are 
recurrent, intensive, irrational persistent thoughts, images or 
impulses, when tried to control causes stress so the person 
tries to control them with some other thought or action. 
Compulsions are the behaviors or mental acts are aimed at 
preventing or reducing distress or preventing some dreaded 
event or situation. However these behaviors or mental acts are 
not connected in a realistic way with what they are designed 
to neutralize
8
. 
CASE REPORT 
A 45 year old man was admitted to Basaveshwara medical 
college hospital and research center, Chitradurga with the 
complaints of increased aggression, decreased sleep, 
increased talk and increased anger since 1 week. This patient 
is a known case of Bipolar affective disorder which was 
previously diagnosed and treated in NIMHANS 2008 & 
Chitradurga Government Hospital for the same problem. 
Regarding his family history, his father and grandfather had 
same type of disorder when he was 10 years of age.  He is 
press reporter, before admitting to NIMHANS hospital he was 
abusing alprazolam at the dose of 1-2mg/day since 5-6years 
(2002-2008) for decrease sleep. He gives up this drug and 
following the treatment in NIHMANS Tab. Olanzepine 
30mg/day, Tab Chlorpromazine 600mg/day, 
Tab.Trihydroxyphendyl 12 mg/day, Tab.lithium 300mg twice 
daily and in social history he used alcohol and smoked 
cigarette.
 
INVESTIGATIONS DURING HOSPITALIZATION 
Blood parameters like total count, differential count, thyroid 
profile, liver function test, and renal profile were normal 
level.  
DISCUSSION  
Bipolar disorder is one of the most common disorder of the 
severe chronic psychiatric disorders
9
. Here in the past history 
patient was admitted in NIHMANS Hospital Bangalore, 
INDIA in 2008 for same symptoms and diagnosed as Bipolar 
affective disorder. This disorder is manic-depressive disorder 
which causes radical emotional changes from manic high to 
depressive lows. It is caused by various factors like genetic 
factors, biological factors and environmental factors. In this 
patient one of the causes for this bipolar disorder is hereditary 
because in his family history his father had suffered with 
same disorder when he was at the age of 10years old and his 
grandfather also had this disorder. While observing some 
previous studies genetics play a major role in Bipolar disorder 
and it runs in the families, and there is also evidence that 
environment and lifestyle issues have an effect on the Bipolar 
disorder's severity
10
. Alcohol and nicotine abuse worsen the 
condition of Bipolar disorder and make very difficult to treat 
this disorder 
11
. This patient has Alcohol dependence 
ABSTRACT 
Bipolar affective disorder currently in mania has been well documented. There are few studies regarding co-morbidity in 
Bipolar affective disorder currently in mania. Here our aim is to report such a case who presented with bipolar affective 
disorder currently in mania with psychotic features, co-morbidity of obsessive compulsive disorder, Alcoholic dependence 
syndrome and Nicotine dependence syndrome. Treatment approaches in co morbid condition. 
Key words: Bipolar affective disorder, Mania, Co-morbidity, Alcohol dependence syndrome (ADS), Nicotine dependence 
syndrome (NDS) 
 
Mudigubba et al                                   Journal of Drug Delivery & Therapeutics; 2013, 3(3), 141-142   142 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
syndrome, Nicotine dependence syndrome. So in this patient 
bipolar disorder currently mania is genetically developed 
along with this he may be affected by alcohol, nicotine and 
alprazolam severely, that’s why the condition of patient in 
manic state is high and even though the treatment is good but 
his condition is not controlled. Obsessive-compulsive 
disorder, Alcohol dependence syndrome, Nicotine 
dependence syndrome and substance use disorders are poorly 
understood because patients with comorbid disorders are 
generally omitted from the clinical trials
12 
. 
 
Treatment for the 
bipolar disorder is vary from the patient to patient based on 
the individual clinical presentation, severity, and frequency of 
episodes. But primarily psychotherapy which is the first 
option of nonpharmacological therapy. Based on randomized 
trials pharmacological treatment are  Mood 
stabilizers(Lithium ,Valproate), Anti-psychotics and Anti-
convulsants  are used. Most  probably monotherapy is used 
but based on the severity of the illness and comorbidity, 
combinational pharmacotherapy is used like lithium plus 
antipsychotics 
(Aripiprazole,Clozapine,Haloperidol,Olanzapine 
,Respiridone,Quetiapine,Ziprasidone) but there is no head-to-
head trails for comparision of antipsychotics in combination 
with lithium or valproate but choice is based on previous 
medication response , side effects , comorbid conditions, 
drug-drug interactions
13
. Lihium is more effective in patients 
with pure mania but it is less effective in patients with 
comorbidity of psychotic features and substance abuse. 
Another mood stabilizer valproate shows more effective in 
bipolar disorder with comorbidity of substance abuse and 
psychotic features when compared to lithium 
9
.   There is also 
evidence to suggest that these subtypes of bipolar disorder 
have shown different responses to medications (Prien et al. 
1988) and there was a literature on the use of lithium, 
valproate, and naltrexone for the treatment of  comorbid 
bipolar patients
14,15 
Here in this  patient has given  treatment 
Injection Olanzepine 10mg BD which is anti-psychotic drug 
and injection vitamin B-complex TID which is used in 
supporting the manic-depression treatment while patient was 
on hospitalization, and on  discharging Tab. Lithium 
carbonate extended release 400mg twice a day for one week  
and Tab.Olanzapine 10 mg  is prescribed. From the studies of 
Geler and colleagues(1998)in a 6–week trial of lithium versus 
placebo in 25 adolescents with bipolar disorder and secondary 
substance dependence, they  found a significant reduction in 
positive urine tests for substances of abuse and significant 
improvement in psychiatric symptoms. This suggests that 
lithium may be a good choice for adolescent substance 
abusers 
14,16
. In some controlled studies of acute mania, mixed 
and depressed phases combinational therapy of lithium or 
valproate with anti-psychotics shows greater efficacy than 
alone. Here olanzapine shows more efficacy in the treatment 
of mania with psychotic features. From the literature in a 
double-blind trails compared with the lithium, valproate, 
haloperidol and placebo olanzapine shows greater efficacy in 
the treatment of acute mania, depression, with or without 
psychotic features
17,18
. Olanzaine is only the anti-psychotic 
drug that has FDA approval for bipolar maintenance therapy. 
Alcohol and nicotine alters the plasma levels of drug 
concentration and interfere with the reduction of therapeutic 
response of lithium and other drugs, so the patients should be 
far away from the usage of these (Alcohol and nicotine) for 
good therapeutic approach. 
CONCLUSION 
According to our study we conclude that Bipolar affective 
disorder is affected by genetic factors, transmissible through 
family’s of first relatives and along with this alcohol 
dependence syndrome and nicotine dependence syndrome 
worsen the course of bipolar disorder and harder to treat.  
There has been little study of the appropriate treatment for 
this co-morbidity. Several studies suggest that mood 
stabilizers particularly valproate (better than lithium)has been 
play a major role in treating alcoholic and nicotinic bipolar 
patients, but head–to–head comparison of lithium and 
valproate has not been carried out. Prescribing of lithium is 
based on the patient good response and his compliance to the 
drug in his previous history. Olanzapine is good antipsychotic 
drug which has FDA approval shows more effective in 
maniac patient with psychotic features. So we have to show 
the special attention on co-morbidities in bipolar affective 
disorder and follow the unbiased practice guidelines for the 
treatment.  
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